We are delighted to announce that Ogibiotec has successfully secured a significant investment round, led by our existing investors Merleview Capital, with continued backing from Scottish Enterprise, TRICAPITAL Angels Limited and Apollo Informal Investments.
What This Means for Ogibiotec
Closing the round marks a key milestone in our mission to scale advanced microbial culturing platforms as we grow our global presence and increase our market engagement.
With this funding we’ll be able to:
- Strengthen our leadership team: bringing in some key strategic hires across the management team and beyond to support operational scale-up, deepen sector expertise and guide the next phase of growth.
- Expand internationally: as we build on early customer success stories in key regions including the UK, Europe, North America and APAC.
- Expand our commercial team: creating new roles in sales, marketing and customer success as we build the commercial and technical infrastructure required to support a global user base.
- Refine our product offering and enhance our software platform: as we continue our commitment to providing the culturing and measurement tools that our customers and the market need to accelerate their innovation and give them the Time To Discover.
From Our CEO, Dr Alex McVey
“We’re delighted to see such a strong commitment from our investors old and new as they continue to show unwavering belief in our team and technology,” says Dr Alex McVey, CEO of Ogibiotec.
“This funding will really allow us to keep our foot flat to the floor as we grow our market base and continue to deliver flexible solutions for culture growth and analysis to our ever expanding customer base.”
Thank You to Our Partners
We extend our deepest thanks to:
- Merleview Capital – for continuing to show active support of our scale-up strategy
- Scottish Enterprise – for ongoing investment in Scottish-scale innovation
- TRICAPITAL Angels Limited – for their belief in our growth potential and deep-rooted support within the local ecosystem
- Apollo Informal Investments – for early-stage and continued backing and ongoing strategic guidance
Let’s Talk
If you’re interested in purchasing OGI3, partnering in product development or learning more about our roadmap, please contact us at info@ogibiotec.com.
About Ogibiotec
Ogibiotec is a cutting-edge biotechnology company developing intelligent automation tools for microbiology. Founded to address the frustrations of traditional microbial culturing, Ogibiotec has created a modular system that automates and standardises microbial growth – a core process in biotech, pharma, and life sciences research and manufacturing.
From flavour and fragrance development, through sustainable biomaterial discovery and animal health, the Ogi3 provides the flexible platform needed to accelerate research and development and give you the #TimeToDiscover.
About Our Investors
- Merleview Capital – Growth-stage life sciences investor with a strong track record across biotech and medtech
- Scottish Enterprise – Scotland’s national economic development agency, investing in innovation and growth
- TRICAPITAL Angels Limited – Leading Scottish-based angel network focused on high-tech and early-stage innovations
- Apollo Informal Investments – Early-stage investor providing capital and strategic support to scaling businesses
We’re really looking forward to this next chapter in our history and look forward to sharing updates on product launches, partnerships and customer success stories.